Pfizer ticks off Lyme vaccine milestone, linking booster shot to pediatric antibody response

[cafead]

via Pfizer and Valneva have ticked off another milestone in their Lyme disease vaccine program, showing that booster doses safely trigger immune responses in adolescents and younger children in a phase 2 clinical trial.

article source